Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    21185230 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain
Conditions: High Risk MC4R Genotype;   Low Risk MC4R Genotype;   One Week or Less Antipsychotic Lifetime Exposure
Interventions: Drug: Ziprasidone;   Drug: aripiprazole, quetiapine, or risperidone

Study has passed its completion date and status has not been verified in more than two years.